Investigational New Drug Application (IND) Process Pre-IND Consultation Program: CDER offers a Pre-Investigational New Drug Application (IND) Consultation Program to foster early communications between sponsors and new drug review divisions in order to provide guidance on the data necessary to warrant IND submission. 21CFR Part 312 Investigational New Drug Application... 390k - 56 sec @ 56k www.fda.gov/cder/Regulatory/applications/ind_page_1.htm

Investigational new drug - Wikipedia, the free encyclopedia The United States Food and Drug Administration's investigational new drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state line... en.wikipedia.org/wiki/Investigational_new_drug

Investigational New Drug - Wikipedia, the free encyclopedia The Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines ( The FDA closed its medical marijuana IND program (the Compassionate Investigational New Drug program) in 1991, en.wikipedia.org/wiki/Investigational_New_Drug en.wikipedia.org/wiki/Investigational_New_Drug

Investigational New Drug Application For 'Fat Melting' Injections Investigational New Drug Application For 'Fat Melting' Injections Cleared By The FDA... 242k - 35 sec @ 56k www.medicalnewstoday.com/articles/81496.php www.medicalnewstoday.com/articles/81496.php

Compassionate Investigational New Drug program - Wikipedia, the free The Compassionate Investigational New Drug program, or Compassionate IND, is the Investigational New Drug program allowing a limited number of patients to use National Institute on Drug Abuse-provided medical marijuana grown at the University of Mississippi. Closed to new entrants, there are only seven... en.wikipedia.org/wiki/Compassionate_Investigational_New... en.wikipedia.org/wiki/Compassionate_Investigational_New_Drug_program

SGX Pharmaceuticals Submits Investigational New Drug Application For SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for SGX523. SGX Pharmaceuticals Submits Investigational New Drug Application For SGX523, A Highly Potent, Selective, Orally Bioavailable CMET Inhibitor... 242k - 35 sec @ 56k www.medicalnewstoday.com/articles/90522.php www.medicalnewstoday.com/articles/90522.php

Investigational New Drugs www.springerlink.com/link.asp?id=102916

New Drug Applications New drug applications news from Drugs.com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals. Vimpat (lacosamide) is an investigational anti-convulsant drug for the treatment of partial onset seizures in adults with epilepsy. 209k - 30 sec @ 56k www.drugs.com/new-drug-applications.html www.drugs.com/new-drug-applications.html

Investigational new drug status cleared by FDA for phenoxodiol in Investigational new drug status cleared by FDA for phenoxodiol in oral form WASHINGTON, D.C., WASHINGTON, D.C., June 17, 2003 -- Novogen subsidiary Marshall Edwards Inc. announced that an Investigational New Drug application (IND) has been cleared by the FDA for the start of a phase II clinical trial of phenoxodiol, 209k - 30 sec @ 56k www.drugs.com/news/investigational-new-status-cleared-f... www.drugs.com/news/investigational-new-status-cleared-fda-phenoxodiol-oral-form-3318.html

Investigational new drug applications and new drug FDA also is amending its regulations pertaining to investigational new drug applications (IND's) to require sponsors to tabulate in their annual reports the numbers of subjects enrolled to date in clinical studies for drug and biological products according to age group, gender, and race. 84k - 12 sec @ 56k www.medscape.com/medline/abstract/10177736

Email URL Embed
Embed URL

About · Privacy · Advertise · Careers